Novel Oral Anticoagulants (NOAC) Market By Type ( Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors ), By Application ( Deep Vein Thrombosis (DVT), Pulmonary Embolism, Acute Coronary Syndrome, Hemodialysis ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 188

 ERC 6449

Novel Oral Anticoagulants (NOAC) Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Anticoagulants are the chemical substances which help in preventing the blood from clotting. Blood clots are very helpful in stop bleeding from wounds, but, if they get dislodged from another site and merge in the blood circulation, they can also block the blood vessels and stop the blood flow to different organs of the body, causing strokes, heart attacks, and even death. Anticoagulants work as a blood thinner and are now being frequently used for the patients suffering from thromboembolism. Initially, drugs such as warfarin, which is a vitamin K antagonist, were used as the only oral substitute of anticoagulants. The presence of a few limitations such as need for frequent laboratory monitoring and serious side effects, compelled the medical authorities to come up with a more advanced and relevant medicinal substitute of warfarin. Novel Oral Anticoagulants (NOACs) have emerged out as a new and enhanced medication with potential benefits, which could be administered to the patients dealing with pulmonary disorders and thromboembolism without frequent monitoring. These medicines have very slight intra-patient variations and the dosing is least patient specific as compared to warfarin. However, increased risk of excessive bleeding and adverse gastrointestinal disorders might act as a major restraining factor for the growth of the market. However, its increasing adoption in the regions such as North America, as a result of constantly rising cases of thromboembolism will act as a major opportunity for the market growth. As per a survey, nearly 7% of the total U.S. population is having inherited thrombophilia, which can seriously increase the chances of thrombosis within them.
The report provides detailed qualitative and quantitative analysis of the Global Novel Oral Anticoagulants (NOAC) Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Novel Oral Anticoagulants (NOAC) Market Player Analysis -

The report presents detailed analysis of major players operating in Global Novel Oral Anticoagulants (NOAC) Market. Few of the include Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim , Sanofi, Daiichi Sankyo, Armatheon, Aspen, Astrazeneca, Bayer, Cellceutix, Cosmo Pharmaceuticals, Csl Behring, Eisai, Gsk, Marathon Pharmaceuticals, Ockham Biotech and Perosphere. A detailed coverage on these market players with information on their revenue from NOAC business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global Novel Oral Anticoagulants (NOAC) market is segmented on the basis of type, application and geography. By type, the market is segmented into Direct Thrombin Inhibitors and Direct factor Xa Inhibitors. On the basis of application, the market is categorized as DVT, Pulmonary Embolism, Acute Coronary Syndrome, Hemodialysis and Others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Novel Oral Anticoagulants (NOAC) Market Segmentation

By Type
    • Direct Thrombin Inhibitors
    • Direct Factor Xa Inhibitors

By Application
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism
    • Acute Coronary Syndrome
    • Hemodialysis
    • Others

By Geography
    • North America
              o U.S.
              o Canada
              o Mexico
    • Europe
              o U.K.
              o France
              o Germany
              o Italy
              o Spain
              o Rest of Europe
    • Asia-Pacific
              o China
              o Japan
              o India
              o Korea
              o Rest of APAC
    • South America
              o Brazil
              o Rest of South America
    • Rest of the World
              o Middle East
              o Africa

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

     

    • What was the market size of the Novel Oral Anticoagulants (NOAC) Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Novel Oral Anticoagulants (NOAC) Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?


Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com